Anja Schmidt-Christensen

Anja Schmidt-Christensen

Auto-generated profile, based on publicly available information

Anja Schmidt-Christensen

Department of Experimental Medical Science, Lund University; Lund University Diabetes Centre;

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2005 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
CSClaudia van de Sand
Claudia van de Sand
SHSebastian Horstmann
Sebastian Horstmann
ASAnja Schmidt
Anja Schmidt
ASAngelika Sturm
Angelika Sturm
SBStefanie Bolte
Stefanie Bolte
VHVolker Heussler
Volker Heussler

14 July 2008 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
ASAnja Schmidt-Christensen
Anja Schmidt-Christensen
ASAngelika Sturm
Angelika Sturm
SHSebastian Horstmann
Sebastian Horstmann
VHVolker Heussler
Volker Heussler
Cysteine proteases mediate liberation of Plasmodium berghei merozoites from infected hepatocytes. In an attempt to identify the responsible parasite proteases, we screened the genome of P. berghei for cysteine protease-encoding genes. RT-PCR analyses revealed that transcription of four out of five P. berghei serine repeat antigen (PbSERA) genes was strongly upregulated in late liver stages briefly before the parasitophorous vacuole membrane ruptured to release merozoites into the host cell cytoplasm, suggesting a role of PbSERA proteases in these processes. In order to characterize PbSERA3 processing, we raised an antiserum against a non-conserved region of the protein and generated a transgenic P. berghei strain expressing a TAP-tagged PbSERA3 under the control of the endogenous promoter. Immunofluorescence assays revealed that PbSERA3 leaks into the host cell cytoplasm during merozoite development, where it might contribute to host cell death or activate host cell proteases that execute cell death. Importantly, processed PbSERA3 has been detected by Western blot analysis in cell extracts of schizont-infected cells and merozoite-infected detached hepatic cells.

21 December 2009 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
EPElyzana D. Putrianti
Elyzana D. Putrianti
ASAnja Schmidt-Christensen
Anja Schmidt-Christensen
IAIris Arnold
Iris Arnold
VHVolker T. Heussler
Volker T. Heussler
KMKai Matuschewski
Kai Matuschewski
OSOlivier Silvie
Olivier Silvie
Parasite proteases play key roles in several fundamental steps of the Plasmodium life cycle, including haemoglobin degradation, host cell invasion and parasite egress. Plasmodium exit from infected host cells appears to be mediated by a class of papain-like cysteine proteases called ‘serine repeat antigens’ (SERAs). A SERA subfamily, represented by Plasmodium falciparum SERA5, contains an atypical active site serine residue instead of a catalytic cysteine. Members of this SERAser subfamily are abundantly expressed in asexual blood stages, rendering them attractive drug and vaccine targets. In this study, we show by antibody localization and in vivo fluorescent tagging with the red fluorescent protein mCherry that the two P. berghei serine-type family members, PbSERA1 and PbSERA2, display differential expression towards the final stages of merozoite formation. Via targeted gene replacement, we generated single and double gene knockouts of the P. berghei SERAser genes. These loss-of-function lines progressed normally through the parasite life cycle, suggesting a specialized, non-vital role for serine-type SERAs in vivo. Parasites lacking PbSERAser showed increased expression of the cysteine-type PbSERA3. Compensatory mechanisms between distinct SERA subfamilies may thus explain the absence of phenotypical defect in SERAser disruptants, and challenge the suitability to develop potent antimalarial drugs based on specific inhibitors of Plasmodium serine-type SERAs.

21 August 2013 in Diabetologia
Verified
Journal Article
Closed access
PDF file
ASAnja Schmidt-Christensen
Anja Schmidt-Christensen
LHLisbeth Hansen
Lisbeth Hansen
EIErwin Ilegems
Erwin Ilegems
NFNina Fransén-Pettersson
Nina Fransén-Pettersson
UDUlf Dahl
Ulf Dahl
DHDan Holmberg
Dan Holmberg

27 November 2015 in Diabetologia
Verified
Journal Article
Closed access
PDF file
CBCorinne Berclaz
Corinne Berclaz
ASAnja Schmidt-Christensen
Anja Schmidt-Christensen
DSDaniel Szlag
Daniel Szlag
JEJerome Extermann
Jerome Extermann
LHLisbeth Hansen
Lisbeth Hansen
DHDan Holmberg
Dan Holmberg

1 December 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LHLisbeth Hansen
Lisbeth Hansen
ASAnja Schmidt-Christensen
Anja Schmidt-Christensen
SGShashank Gupta
Shashank Gupta
NFNina Fransén-Pettersson
Nina Fransén-Pettersson
THTine D. Hannibal
Tine D. Hannibal
DHDan Holmberg
Dan Holmberg
Autoimmune diabetes is a consequence of immune-cell infiltration and destruction of pancreatic β-cells in the islets of Langerhans. We analyzed the cellular composition of the insulitic lesions in the autoimmune-prone non-obese diabetic (NOD) mouse and observed a peak in recruitment of plasmacytoid dendritic cells (pDCs) to NOD islets around 8–9 weeks of age. This peak coincides with increased spontaneous expression of type-1-IFN response genes and CpG1585 induced production of IFN-α from NOD islets. The transcription factor E2-2 is specifically required for the maturation of pDCs, and we show that knocking out E2-2 conditionally in CD11c+ cells leads to a reduced recruitment of pDCs to pancreatic islets and reduced CpG1585 induced production of IFN-α during insulitis. As a consequence, insulitis has a less aggressive expression profile of the Th1 cytokine IFN-γ and a markedly reduced diabetes incidence. Collectively, these observations demonstrate a disease-promoting role of E2-2 dependent pDCs in the pancreas during autoimmune diabetes in the NOD mouse.